Cardiol Therapeutics Inc Class A share price logo

Cardiol Therapeutics Inc Class A Share Price

NASDAQ: CRDL

Small Cap

$1.50

+0.09

(+6.74%)

as on

Cardiol Therapeutics Inc Class A Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.39
    $1.51
    downward going graph

    7.33%

    Downside

    0.67%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.88
    $1.59
    downward going graph

    41.33%

    Downside

    6.00%

    Upside

    downward going graph

Cardiol Therapeutics Inc Class A share price movements today

Previous Close
$1.41
Open
$1.42
Volume
2.4M
Day's Low - High
$1.39 - $1.51
52 Week Low - High
$0.88 - $1.59

Cardiol Therapeutics Inc Class A Historical Returns

1 Month Return
+ 53 %
3 Month Return
+ 42.45 %
1 Year Return
+ 49.5 %
3 Year Return
+ 193.09 %
5 Year Return
0 %

Cardiol Therapeutics Inc Class A Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics Inc Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$157.5M

EPS (TTM)

-0.3767

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-34.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-158.75%

Cardiol Therapeutics Inc Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics Inc Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$157.5MNANA0.00%
BUY$25.8BNA21.1241.94%
HOLD$16.3B9.55%NA-24.58%
BUY$43.4BNA19.515.11%
BUY$51.7B-26.99%19.7728.24%

Stock Returns calculator for Cardiol Therapeutics Inc Class A Stock including INR - Dollar returns

The Cardiol Therapeutics Inc Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cardiol Therapeutics Inc Class A investment value today

Current value as on today

₹1,60,886

Returns

₹60,886

(+60.89%)

Returns from Cardiol Therapeutics Inc Class A Stock

₹48,515 (+48.51%)

Dollar Impact

₹12,371 (+12.37%)

Analyst Recommendation on Cardiol Therapeutics Inc Class A Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardiol Therapeutics Inc Class A. Average target price of $7.53

Cardiol Therapeutics Inc Class A Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics Inc Class A.

What analysts predicted

80.08%UPSIDE

Target Price

$7.53

Current Price

$1.5

Analyzed by

8 Analysts

Target

$7.53

Cardiol Therapeutics Inc Class A target price $7.53, a slight upside of 80.08% compared to current price of $1.5. According to 8 analysts rating.

Cardiol Therapeutics Inc Class A Stock’s Investor Sentiment and Interest

Search interest for Cardiol Therapeutics Inc Class A Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Cardiol Therapeutics Inc Class A Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
0
0
-
0
-
-
-
0
Operating Income
-5
-8
-8
-5
-14
-6
-8
-7
-10
-8
EBITDA
-4
-
-8
-4
-13
-5
-8
-7
-9
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-7
-9
-4
-12
-5
-8
-8
-9
-7
Income Tax Expense
-1
-
0
0
-
-
-
-
-
-
Net Income
-3
-5
-6
-3
-9
-3
-5
-8
-9
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
-
-
Operating Income
-7
-10
-16
-30
-30
-22
-40
-34
EBITDA
-7
-10
-16
-24
-22
-21
-40
-34
Interest Expense
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-15
-10
-16
-25
-22
-21
-36
-33
Income Tax Expense
0
0
0
-6
-10
0
-
-
Net Income
-11
-8
-12
-19
-16
-15
-25
-33
Net Profit Margin
0.00%
0.00%
-20570.94%
-40170.87%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc Class A Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-9
-6
-12
-8
-8
-8
-9
-7
Operating Cash Flow
-6
-6
-4
-7
-5
-7
-4
-6
-5
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
18
0
0
0
15
Change in Cash
-6
-6
-4
-8
14
-7
-5
-6
9

Cardiol Therapeutics Inc Class A Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-13
-20
-31
-30
-28
-36
-33
Operating Cash Flow
-10
-11
-9
-23
-27
-25
-25
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
25
2
16
93
0
0
18
15
Change in Cash
14
-9
7
69
-24
-24
-4
-9

Global Institutional Holdings in Cardiol Therapeutics Inc Class A

Funds
Holdings
UBS Group AG
0.05%
AdvisorShares Investments, LLC
0.5%
The Goldman Sachs Group Inc
0.29%
Marshall Wace Asset Management Ltd
0.14%
Citadel Advisors Llc
0.41%

Cardiol Therapeutics Inc Class A News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:15 PM

    -

    Cardiol Therapeutics receives U.S. patent allowance for CardiolRx™ and CRD-38, extending protection until late 2040.

Insights on Cardiol Therapeutics Inc Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CRDL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CRDL stock has moved up by 59.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 106.6% return, outperforming this stock by 57.1%

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
OrganisationCardiol Therapeutics Inc Class A
Headquarters2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. David G. Elsley MBA
E-voting on sharesClick here to vote

Key Management of Cardiol Therapeutics Inc Class A

Name

Title

Mr. David G. Elsley MBA

President, CEO & Director

Mr. Bernard Lim B.Sc.

Chief Operating Officer

Dr. Andrew Warwick Hamer M.D.

Chief Medical Officer and Head of Research & Development

Trevor Burns

Investor Relations

Mr. John A. Geddes BSCPT, MBA

Vice President of Corporate Development

FAQs

What is Cardiol Therapeutics Inc Class A share price today?

Cardiol Therapeutics Inc Class A share price today is $1.5 as on at the close of the market. Cardiol Therapeutics Inc Class A share today touched a day high of $1.51 and a low of $1.39.

What is the 52 week high and 52 week low for Cardiol Therapeutics Inc Class A share?

Cardiol Therapeutics Inc Class A share touched a 52 week high of $1.59 on and a 52 week low of $0.88 on . Cardiol Therapeutics Inc Class A stock price today i.e. is closed at $1.5,which is 5.66% down from its 52 week high and 70.45% up from its 52 week low.

What is Cardiol Therapeutics Inc Class A's market capitalisation today?

Cardiol Therapeutics Inc Class A market capitalisation is $0.00T as on .

How to invest in Cardiol Therapeutics Inc Class A Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics Inc Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Inc Class A Shares that will get you 1.0000 shares as per Cardiol Therapeutics Inc Class A share price of $1.5 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cardiol Therapeutics Inc Class A Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics Inc Class A (CRDL) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Cardiol Therapeutics Inc Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Cardiol Therapeutics Inc Class A share’s latest price of $1.5 as on April 18, 2026 at 1:29 am IST, you will get 6.6667 shares of Cardiol Therapeutics Inc Class A. Learn more about fractional shares .